Literature DB >> 31668676

Tumor Immunosurveillance and Immunotherapies: A Fresh Look from Intravital Imaging.

Morgane Boulch1, Capucine L Grandjean2, Marine Cazaux3, Philippe Bousso4.   

Abstract

Understanding complex interactions between the immune system and the tumor microenvironment is an essential step towards the rational development and optimization of immunotherapies. Several experimental approaches are available to tackle this complexity but most are not designed to address the dynamic features of immune reactions, including cell migration, cellular interactions, and transient signaling events. By providing a unique means to access these precious parameters, intravital imaging offers a fresh look at intratumoral immune responses at the single-cell level. Here, we discuss how in vivo imaging sheds light on fundamental aspects of tumor immunity and helps elucidate modes of action of immunotherapies. We conclude by discussing future developments that may consolidate the unique contribution of intravital imaging for our understanding of tumor immunity.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  immunosurveillance; immunotherapy; intravital imaging; tumor immunity; two-photon microscopy

Mesh:

Year:  2019        PMID: 31668676     DOI: 10.1016/j.it.2019.09.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  14 in total

Review 1.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

2.  Characterizing the landscape of cervical squamous cell carcinoma immune microenvironment by integrating the single-cell transcriptomics and RNA-Seq.

Authors:  Ruiling Yin; Xiuming Zhai; Hongyan Han; Xuedong Tong; Yan Li; Kun Deng
Journal:  Immun Inflamm Dis       Date:  2022-06

Review 3.  Intravital and high-content multiplex imaging of the immune system.

Authors:  Jyh Liang Hor; Ronald N Germain
Journal:  Trends Cell Biol       Date:  2021-12-14       Impact factor: 21.167

4.  Visualizing Spatial and Stoichiometric Barriers to Bispecific T-Cell Engager Efficacy.

Authors:  Ran You; Jordan Artichoker; Arja Ray; Hugo Gonzalez Velozo; Dan A Rock; Kip P Conner; Matthew F Krummel
Journal:  Cancer Immunol Res       Date:  2022-06-03       Impact factor: 12.020

Review 5.  3D imaging for driving cancer discovery.

Authors:  Ravian L van Ineveld; Esmée J van Vliet; Ellen J Wehrens; Maria Alieva; Anne C Rios
Journal:  EMBO J       Date:  2022-04-11       Impact factor: 14.012

6.  HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment.

Authors:  Yongling Ning; Jun Ding; Xiao Sun; Yewen Xie; Mingming Su; Chenglong Ma; Jie Pan; Jie Chen; Hua Jiang; Chunjian Qi
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

7.  Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis.

Authors:  Capucine L Grandjean; Zacarias Garcia; Fabrice Lemaître; Béatrice Bréart; Philippe Bousso
Journal:  Sci Adv       Date:  2021-02-19       Impact factor: 14.136

8.  Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma Model.

Authors:  Doreen Lau; Fabien Garçon; Anita Chandra; Laura M Lechermann; Luigi Aloj; Edwin R Chilvers; Pippa G Corrie; Klaus Okkenhaug; Ferdia A Gallagher
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

Review 9.  Coordinating Cytoskeleton and Molecular Traffic in T Cell Migration, Activation, and Effector Functions.

Authors:  Marta Mastrogiovanni; Marie Juzans; Andrés Alcover; Vincenzo Di Bartolo
Journal:  Front Cell Dev Biol       Date:  2020-10-21

Review 10.  Live Imaging of Innate and Adaptive Immune Responses in the Liver.

Authors:  Lu Li; Zhutian Zeng
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.